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Abstract
Introduction
Knee pain is common in adolescents and adults and is associated with an increased risk of
developing knee osteoarthritis. The aim of this systematic review was to gather and appraise
the cost-effectiveness of treatment approaches for non-osteoarthritic knee pain conditions.
Method
A systematic review was conducted according to the PRISMA guidelines and registered on
PROSPERO (CRD42016050683). The literature search was done in MEDLINE via
PubMed, EMBASE, The Cochrane Library, and the National Health Service Economic Eval-
uation Database. Study selection was carried out by two independent reviewers and data
were extracted using a customized extraction form. Study quality was assessed using the
Consensus on Health Economic Criteria list.
Results
Fifteen studies were included. The majority regarded the treatment of anterior cruciate liga-
ment (ACL) injuries, but we also identified studies evaluating other knee pain conditions
such as meniscus injuries, cartilage defects, and patellofemoral pain syndrome. Study inter-
ventions were categorized as surgical or non-surgical interventions. The surgical interven-
tions included ACL reconstruction, chondrocyte implantation, meniscus scaffold procedure,
meniscal allograft transplantation, partial meniscectomy, microfracture, and different types
of autografts and allografts. The non-surgical management consisted of physical therapy,
rehabilitation, exercise, counselling, bracing, and advice. In general, for ACL injuries surgi-
cal management alone or in combination with rehabilitation appeared to be cost-effective.
The quality of the economic evaluations was of moderate to high quality.
Conclusion
There was insufficient evidence to give a firm overview of cost-effective interventions for
non-osteoarthritic knee pain, but surgical treatment of acute ACL injury appeared cost-
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effective. There is very little data regarding the cost-effectiveness of non-surgical interven-
tions for non-traumatic knee conditions.
Introduction
Knee pain is a common symptom in both adolescents and adults[1]. It is a common symptom
from around the age of 10 years and by the age of 15 one in every three adolescents will report
to have some level of knee pain[2]. The prevalence of knee pain continues to be high all through
adulthood[3]. Most commonly, knee pain has a non-traumatic onset[4,5]. In young people the
majority will develop knee pain with an insidious onset without a prior trauma while one third
will develop pain after a trauma to the knee. The same patterns hold true for adults[6]. Meniscal
tears and ligament injuries are some of the most frequent traumatic knee injuries with anterior
cruciate ligament (ACL) and medial collateral ligament (MCL) injury being the most common
[7]. Furthermore, sports injuries are associated with increased knee pain[8]. The overall burden
of sports-related injuries is high with a cost of about EUR 56 m annually for knee/lower leg inju-
ries[8]. The knee has a high weight-loading and changes in the biomechanics of the joint may
cause pain and harm the knee[9,10]. Knee pain during adolescence and traumatic injuries such
as ACL and meniscal injuries may increase the risk of developing knee osteoarthritis (OA), and
subsequent pain and functional impairment[11–13]. These findings constitute a strong ratio-
nale behind increasing knee pain treatment efforts and to prevent OA in the longer-term.
The utilization of health care and costs associated with knee pain and knee injuries is sub-
stantial. A lifetime cumulative proportion calculation showed about 13% of adults reporting to
have seen their general practitioner (GP) and 6.8% was referred to secondary care due to knee
pain[14]. In the USA, the incidence rate of cruciate ligament injuries is about 250.000 injuries
per year. The associated surgical and the rehabilitative costs of one cruciate ligament injury
has been estimated to be about EUR 11.500. This corresponds to a total cost of EUR 2.9 bn per
year which signifies the substantial economic burden of knee pain to society[15,16].
The choice of treatment for knee pain depends on the specific diagnosis, the patient, and
the available resources. The main treatment options are often classified into: Information/
advice, conservative treatment, exercise therapy, medications, surgery, and others (e.g. manip-
ulation and acupuncture[17]. Preventive interventions have shown to be effective in prevent-
ing knee pain in young and adult population[18]. However, there is no consensus about the
optimal treatment of non-osteoarthritic knee pain[19–21]. Due to an increasing number of
treatment approaches available and the global economic burden of knee pain, it is important
to increase the knowledge of the cost-effectiveness of the different treatment options for knee
pain conditions to enable informed resource utilization. To our knowledge, no systematic
review has yet synthesised the evidence on the cost-effectiveness of non-osteoarthritic knee
pain management. The aim of this systematic review was to identify, gather, and appraise stud-
ies reporting on the cost-effectiveness of different treatment approaches for non-osteoarthritic
knee pain conditions in adolescents and adults to identify cost-effective treatments.
Materials and methods
The present study is based on a systematic review and the reporting follows the PRISMA
guidelines[22], See S1 PRISMA. It is prospectively registered in PROSPERO (Registration
number: CRD42016050683).
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Study identification
We conducted a systematic search in the following major electronic databases: MEDLINE via
PubMed, EMBASE, and The Cochrane Library. Furthermore, a search was conducted for
studies related to health economics in the National Health Service Economic Evaluation Data-
base (NHS EED). The search was expanded by reviewing the references of the included studies
to identify further relevant publications. The search was not limited to time of publication, but
language-restricted to Danish, English, Swedish, and Norwegian.
The search strategy was developed using the Patient, Intervention, Comparator, Out-
come (PICO) approach and included thesaurus terms and free terms relating to or describ-
ing the condition and health economic outcomes, see S1 Search Strategy. PICO model is a
way of defining clinical question in terms of specific patient problem and helps defining
the research question. The ‘Patient’ in this review was knee pain conditions and the ‘Out-
come’ was cost-effectiveness. Terms related to these words were combined in the search
strategy. The initial search was conducted on 28th of November 2016 and was repeated on
28th of March 2017 just before the final analyses to retrieve possible further studies for
inclusion. A list of predetermined inclusion and exclusion criteria for study identification
is presented in Table 1.
Study selection and data extraction
Study selection was carried out through two stages by two independent reviewers (TA and
MVF). In the first stage, clearly irrelevant publications were excluded by screening the titles
and abstracts. Publications were included in the second stage if the studies met the inclusion
criteria from the first stage as well as studies for which exclusion or inclusion could not be
made based on title and abstract alone. The full text of potentially eligible studies was retrieved
and assessed for eligibility by two independent reviewers (TA and MVF). Any disagreement
between the reviewers about the eligibility of a study was resolved through discussion with a
third reviewer (MBJ).
The data were extracted by two independent reviewers (TA and MVF) using a standardized
data extraction form. See S1 Extraction form. The extracted data were compared for consis-
tency, which was resolved through discussion and assessment of the original paper. Informa-
tion about study design, participants and intervention characteristics, methods, and outcome
measures was extracted.
Table 1. Inclusion and exclusion criteria.
Inclusion Exclusion
Full-text paper published in peer-reviewed journals Not peer-reviewed paper
Model-based and trial-based economic evaluations (e.g. CBA, CUA, CEA,
CCA)
Effectiveness studies
Comparison of two or more interventions according to both costs and
consequences
Cost studies of single interventions
Adolescents or adults (age 10–65) Children (age<10) and elderly (65+)
Pharmacological, non-pharmacological, conventional, invasive (surgical),
and noninvasive treatments of knee pain in primary and secondary
healthcare
Alternative treatment (e.g. healing,
mindfulness)
Economic evaluations performed from a societal or/and narrower
perspective
Knee pain caused by arthritis or/and
osteoarthritis
CBA: cost-benefit analysis, CCA: cost-consequence analysis, CEA: cost-effectiveness, CUA: cost-utility analysis
https://doi.org/10.1371/journal.pone.0209240.t001
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Quality assessment and data synthesis
The Consensus Health Economic Criteria (CHEC) list was applied to assess the methodologi-
cal quality of the economic evaluations by two independent reviewers (TA and ASV)[23], See
S1 CHEC list. The CHEC list is composed of 19 questions with each question assigned with
either a ‘yes’ or ‘no’, and is recommended for assessing the quality of economic evaluations
[23]. The two reviewers confirmed or disconfirmed compliance with each of the assessment
questions based on subjective evaluation of the papers. Any disagreement was resolved
through discussion and a third review member (LHE) was involved if disagreement remained.
S1 Appendix shows the items of the list along with an explanation of how the items were inter-
preted for application for the included studies. As the checklist does not provide summary
scores, score limits were defined by the authors. If a study received ‘yes’ score higher than 75%
of all items, it was defined as a high-quality economic evaluation. Studies that scored higher
than 50% up to 75% were considered moderate quality evaluations. If studies scored lower
than 50%, they were considered low quality evaluations. Furthermore, the different items of
the CHEC list were weighted equally in the scoring algorithm. A narrative synthesis was used
to analyse, summarize, and present the information provided in the included studies. The col-
lected data was synthesized using a mapping strategy to provide an overview of the economic
evidence of surgical interventions versus non-surgical interventions. When comparison was
written in the form A vs B, A was considered the intervention and B was considered control.
The data was analysed and combined according to the type of knee pain conditions, interven-
tions and/or type of outcome measure. The type of modelling was assessed by finding the
method used, e.g. Markov models or decision tree. For cost-effectiveness of interventions,
authors conclusions were reported as the different economic evaluations complied with differ-
ent criteria for cost-effectiveness.
Furthermore, the costs reported in the original studies were converted to 2016 EUR to
account for differential timing and different currencies. Figures was converted using the coun-
try’s consumer price index from 1st January of the cost year to 1st January of 2016[24]. The
costs were eventually converted to EUR using the exchange rates of January 2016[25].
Results
The initial search resulted in 2334 unique records of which 638 records were excluded because
they concerned osteoarthritic knee pain patients, were not economic evaluations, and included
reviews. Furthermore, 1329 records were excluded as they did not concern knee pain, were
conference abstracts, or the articles did not meet the inclusion criteria. This resulted in 44 rec-
ords of which 29 were excluded due to the fact that they did concern osteoarthritic knee pain
patients, the economic evaluations did not have a comparison or did not include effect in the
economic evaluations or included prevention/screening programs. This resulted in 14 studies
eligible for inclusion with one additional study found through final search. The present sys-
tematic review included 15 studies[26–40], see Fig 1.
Overview of the identified studies
An overview of the studies is given in Table 2. The studies were conducted from 1999 to 2017
in seven different countries in Europe and the USA and included young and adult patient pop-
ulations (>16 years of age). The studies evaluated the following pain conditions: ACL injuries,
chondral defects, traumatic meniscus injuries, and patellofemoral pain syndrome (PFPS). Of
the included studies, seven of the studies compared ACL reconstruction of the knee to differ-
ent initial non-surgical management forms, including counselling, bracing, and physical ther-
apy, or conservative management with optional surgery[26–32]. Seven studies compared one
Systematic review of cost-effective knee pain treatments
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surgical management to another surgical management. The surgical management forms
included ACL reconstruction, chondrocyte implantation, meniscus scaffold procedure, menis-
cal allograft transplantation, partial meniscectomy, microfracture, and different types of auto-
and allografts[33–39]. Only one study assessed the cost-effectiveness of a non-surgical man-
agement versus a non-surgical management. The study compared physical therapy to usual
care consisting of advice and information[40].
Overview of the identified economic evaluations
All included studies performed a cost-utility analysis (CUA) having quality-adjusted life years
(QALYs) as outcome measurement[26–36,38–40], except for one, which consisted of a cost-
effectiveness analysis (CEA) with outcome measured as years to total knee alloplastic (TKA)
and the subsequent incremental cost-effectiveness ratio reported as cost per year to arthro-
plasty gained[37]. Nine of the studies performed model-based economic evaluations with
input data from the best evidence available in the literature[26,29,30,32,33,36–39] while the
remaining seven performed economic evaluations with data from clinical trials and cohort
studies[27,28,31,34,35,40]. The time horizon of the studies varied from one year to lifetime. A
societal perspective was adopted in eight of the studies[27–29,31,36,38,39,40] while five studies
adopted a healthcare perspective or third payers’ perspective such as the National Health Ser-
vice (NHS)[30,32,34,35,37]. The remaining two studies did not explicitly report the actual per-
spective[26,33]. Utility was measured by the EuroQol-5-Dimensions-3-Levels instrument
(EQ-5D-3L), The Short Form (SF)-36 questionnaire, and utility measured based on functional
activity classes. Discounting was carried out to account for the effect of preferential timing in
11 out of 13 studies that had a follow-up time greater than one year[26–29,31,32,34–38,40].
Fig 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart. Numbers in
parenthesis in the box indicate the number of studies after each phase. Number in parenthesis in the lowermost
box indicates the number of studies included in the review. Fifteen papers were retrained as they met the inclusion and
exclusion criteria[26–40].
https://doi.org/10.1371/journal.pone.0209240.g001
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Two studies did not explicitly mention the approach to discounting of costs and benefits
[30,33]. Furthermore, all the studies performed sensitivity analyses to assess the robustness of
the models.
The methodological quality of the studies by assessment of the CHEC list varied with nine
of the studies rated as “high quality”[27,29,31,34–37,39,40] and the remaining six rated as
“moderate quality”[26,28,30,32,33,38]. Most commonly, the inappropriately reported or miss-
ing items in the CHEC list was: 1) Time horizon, 2) perspective of the analysis, 3) discussion of
the generalizability of the studies, and 4) discussion of ethical and distributional issues. No
Table 2. Overview of the identified studies.
Study (Year) Interventions Country Population Reference
Surgery compared to non-surgical initial treatment
Anterior cruciate ligament injury
Gottlob et al
(1999)
ACL reconstruction with a patellar tendon autograft
compared to rehabilitation, counselling and functional
bracing.
The United
States
Young adults in their late teens and 20’s, acute ACL tear. [26]
Mather III
et al (2013)
ACL reconstruction compared to structured rehabilitation
plus optional delayed reconstruction.
The United
States
General population age 12–45 years, ACL tear. [27]
Mather III
et al (2012)
Early ACL reconstruction compared to rehabilitation. The United
States
General population age 12–45 years, ACL tear. [28]
Stewart et al
(2016)
ACL reconstruction compared to physical therapy. The United
States
Competitive athletes, complete ACL tear. [29]
Farshad et al
(2011)
Surgical ACL reconstruction compared to conservative
treatment.
Switzerland General population, average age of 30–35 years, ACL
rupture.
[30]
Kiadaliri et al
(2016)
Structured rehabilitation plus early ACL reconstruction
compared to structured rehabilitation plus optional delayed
ACL reconstruction.
Sweden Active adults, 18–35 years of age, acute ACL injury. [31]
Bierbaum et al
(2017)
DIS reconstruction compared to wait and see (muscular
training plus delayed ACL reconstruction).
Germany Patients with an isolated rupture of the ACL with or
without meniscal injury.
[32]
Surgery compared to surgery management
Cartilage defects
Derrett et al
(2005)
Autologous chondrocyte implantation compared to
mosaicplasty.
United
Kingdom
General population, 16+ years, chondral or
osteochondral lesions of >1 cm diameter.
[33]
Elvidge et al
(2016)
Characterised Chondrocyte implantation compared to
microfracture.
United
Kingdom
General population, aged 18–50, cartilage damage. [34]
Gerlier et al
(2010)
ChondroCelect cell therapy compared to microfracture. Belgium Adult patients, aged <50 years, symptomatic cartilage
lesions of the femoral condyles.
[35]
Traumatic meniscus injury
Rongen et al
(2016)
Meniscus scaffold procedure compared to standard
meniscectomy
The
Netherlands
General population, mean age of 39 years, patients with
an acute traumatic or degenerative irreparable medial
meniscus injury.
[36]
Ramme et al
(2016)
Meniscal allograft transplantation compared to partial
meniscectomy.
The United
States
Active athletic women, aged 25–30 years old with normal
BMI, discoid lateral meniscus tears.
[37]
Anterior cruciate ligament
Paxton et al
(2010)
Single-bundle versus double-bundle autograft ACL
reconstruction.
The United
States
Young healthy person, ACL tear [38]
Genuario et al
(2012)
Bone–patellar tendon–bone autografts, quadrupled hamstring
tendon autografts, and allografts compared with each other.
The United
States
Subjects in a sports medicine clinic, ACL injury. [39]
Exercise compared to usual care
Patellofemoral pain syndrome
Tan et al
(2010)
Exercise therapy compared to ‘‘usual care”. The
Netherlands
Adolescents and young adults, age 14–40 years, PFPS. [40]
ACL: anterior cruciate ligament, BMI: body mass index, DIS: dynamic intraligamentary stabilization, PFPS: patellofemoral pain syndrome.
https://doi.org/10.1371/journal.pone.0209240.t002
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studies were rated as “low quality”. Characteristics of the economic evaluations including the
CHEC score is given in Table 3.
Furthermore, a permutation matrix was conducted to summarise the cost-effectiveness of
interventions. It is a visual illustration showing permutation that indicate a certain treatments’
incremental cost and incremental effectiveness. Four studies in this review accepted the inter-
ventions being assessed with lower costs and better effectiveness associated with the interven-
tion compared to the comparator. Based on the remaining 11 studies, an obvious decision
could not be conducted because the interventions had higher costs and lower effectiveness
when compared to the comparator. Fig 2 is an illustration of the permutation matrix.
Table 3. Characteristics of the economic evaluations.
Study [Reference] Study type Time horizon Perspective ICER (EUR 2016) CHEC
Surgery compared to non-surgical initial treatment
Chronic anterior cruciate ligament injury
Gottlob et al [26] Model-based
CUA
Seven years N/A 7.730 per QALY 53%
Mather III et al
[27]
Trial-based CUA Model 1: Six years
Model 2: lifetime
Societal Model 1: Cost saving of 4.240 and QALY gain of 0.18.
Model 2: Cost saving of 47.474 and QALY gain of
0.72.
79%
Mather III et al
[28]
Trial-based CUA Six years Societal ER group: 3.713 per QALY
DR group: 4.242 per QALY
74%
Stewart et al [29] Model-based
CUA
Six years Societal 20.778 per QALY 84%
Farshad et al [30] Model-based
CUA
90 months Third party payers 4.815 per QALY 53%
Kiadaliri et al [31] Trial-based CUA Five years Societal Early ACL: 25.686 and 3,96 QALY
Optional delayed ACL group: 21.060 and 3,83 QALY.
84%
Bierbaum et al [32] Model-based
CUA
Three years The community of insured
citizens.
9,092.66 per QALY 68%
Surgery compared to surgery management
Cartilage defects
Derrett et al [33] Model-based
CUA
Two years N/A 28.723 per QALY 58%
Elvidge et al [34] Trial-based CEA 75 years NHS 28.788 per QALY 89%
Gerlier et al [35] Trial-based CUA 40 years Global healthcare payer
perspective
18.073 per QALY 84%
Traumatic meniscus injury
Rongen et al [36] Model-based
CUA
Model 1: lifetime
Model 2: five years
Societal 297.727 per QALY. 84%
Ramme et al [37] Model-based CEA 25 years Healthcare system 771 per-year-gained in time to TKA. 79%
Anterior cruciate ligament injury
Paxton et al [38] Model-based
CUA
12 years
postoperatively
Societal 6.420 per QALY 68%
Genuario et al [39] Model-based
CUA
One year Societal HS: 5.140 and 0,912 QALY
BPTB: 4.917 and 0,966 QALY
Allografts: 6.656 and 0,904 QALY
79%
Exercise compared to usual care
Patellofemoral pain syndrome
Tan et al [40] Trial-based CUA One year Societal and healthcare 16.299 saving per QALY gained 79%
ACL: anterior cruciate ligament, BPTB: bone-patellar-tendon-bone, CEA: cost-effectiveness analysis, CUA: cost-utility analysis, HS: hamstring, ICER: incremental cost-
effectiveness ratio, N/A: not applicable, TKA: total knee arthroplasty, QALY: quality-adjusted life year.
https://doi.org/10.1371/journal.pone.0209240.t003
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Findings of the identified studies
Surgical vs non-surgical initial treatment of acute ACL injury. Four studies compared a
surgical approach to treatment of ACL injury to a non-surgical management alone. Gottlob
et al.[26] compared ACL reconstruction with a patellar tendon autograft to a combination of
rehabilitation, counselling, and functional bracing. The surgical treatment resulted in higher
costs with increased benefit compared to the non-surgical strategy. This corresponded to an
incremental cost-effectiveness ratio (ICER) of EUR 7.730 per QALY, making ACL reconstruc-
tion a cost-effective strategy compared to the non-surgical treatment assuming a willingness-
to-pay (WTP) of about EUR 18.200 (converted from 1999 CAD to 2016 EUR). Mather et al.
[27], Stewart et al.[29], and Farshad et al.[30] compared ACL reconstruction with structured
rehabilitation, physical therapy, and conservative treatment, respectively. From a societal per-
spective, ACL reconstruction provided reduced costs with greater benefit when compared to
non-surgical management[28,30]. Although the third-party payer perspective was applied in
the study by Farshad et al.[30], the ACL surgery was shown to be cost-effective, despite
increased costs (ICER: EUR 4.815 per QALY).
Three studies compared a surgical approach to non-surgical plus optional/delayed surgical
management[29,32,33]. The study by Mather et al.[28] compared early ACL reconstruction to
rehabilitation plus optional delayed reconstruction. In the six-year time horizon, early recon-
struction dominated rehabilitation plus optional delayed reconstruction from a societal perspec-
tive meaning that early reconstruction was associated with both reduced cost and increased
QALYs. After a five-year follow-up, early reconstruction was associated with a slight increase in
Fig 2. Permutation matrix for possible outcomes of economic evaluations for studies of interventions vs comparator. The letters indicate if the intervention should be
accepted, rejected or there is no obvious decision to make. The shading offers a means of more easily identifying the implications for decision making.
https://doi.org/10.1371/journal.pone.0209240.g002
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costs and increased QALYs from a societal perspective, but the difference from optional delayed
reconstruction was not statistically significant[31].
Bierbaum et al.[32] evaluated a new treatment option for ACL reconstruction (dynamic
intraligamentary stabilization (DIS)) compared to a ‘wait and see’ approach (rehabilitation
with optional delayed ACL surgery) in a German setting. The model identified the DIS strategy
to be more effective with 2.34 QALY compared to 2.26 QALY for the ‘wait and see’ approach.
Though the costs of the DIS treatment was higher, the study concluded DIS to offer potential
benefits to the patient with increased quality of life compared to ‘wait and see’ approach.
Surgical vs. surgical treatment of cartilage defects. Derrett et al.[33] found that autolo-
gous chondrocyte implantation (ACI) was more expensive and more effective than mosaic-
plasty for the treatment of chondral defects of the knee cartilage in a young population. The
authors concluded that ACI was cost-effective if a WTP threshold of EUR 40.651 (Converted
from 2016 GBP) per QALY was applied (ICER: EUR 28.723 per additional QALY). Chondro-
Cyte implantation (CCI) was also examined by Elvidge et al.[34] and Gerlier et al.[35] for treat-
ment of cartilage damage of the knee and symptomatic cartilage lesions of the knee,
respectively. In both studies the implantation seemed to be cost-effective with better health
outcomes and potentially reduced costs.
Surgical vs. surgical treatment of traumatic meniscus injury. Rongen et al.[36] con-
ducted two models comparing a meniscus scaffold procedure with standard treatment defined
as partial meniscectomy removing as little of the meniscus as possible. Both models showed
ICER values above a WTP threshold of EUR 27.100 (Converted from 2016 GBP) per QALY,
indicating that neither of the health technologies would be cost-effective. However, meniscal
allografts have shown to reduce pain and improve function in patients with discoid lateral
meniscus tears by a model-based CEA conducted by Ramme et al.[37] when compared to par-
tial meniscectomy. Over a 25-year period, a strategy of partial meniscectomy was less expen-
sive compared to using meniscal allograft, but the meniscal allograft strategy postponed TKA
by an average of 17.3 years compared to 12.5 years for partial meniscectomy. Thus, although
meniscal allograft is costlier, it might be effective in delaying TKA.
Surgical vs. surgical treatment of ACL injury. A comparison of three graft types showed
that the hamstring autograft was the most effective and the least expensive graft choice when
compared to bone-patella-tendon bone autograft and allografts for treatment of ACL injury.
Indeed, allografts were the least effective and most costly graft type[39]. A model-based CUA
was conducted by Paxton et al. to examine the cost-effectiveness of single-bundle versus dou-
ble-bundle autograft choices for ACL reconstruction. The double-bundle ACL reconstruction
was more expensive and more effective. Paxton et al.[38] concluded that, despite increased
upfront costs, the double-bundle reconstruction might be cost-effective.
Exercise therapy vs. usual care for treatment of PFPS. The study by Tan et al.[40] is the
only economic evaluation, which compared an exercise therapy comprising advice, informa-
tion and a standardized 6-week exercise program with usual care alone, which was defined as
advice and information about the patellofemoral pain syndrome (PFPS). The study was con-
cluded that exercise therapy was a cost-effective treatment approach with reduced costs and
increased QALYs compared to usual care for the management of PFPS in adolescents and
young adults.
Discussion
Identified studies
Due to the diversity of the knee pain conditions and interventions in the identified literature,
an overall conclusion regarding cost-effective treatments cannot be made. However, most of
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the studies regarded ACL injuries, where ACL reconstruction showed to be overall cost-effec-
tive. Some studies evaluated different interventions for other knee pain conditions such as car-
tilage damage and meniscus injuries. Based on the identified literature, there is scarce
knowledge about the cost-effectiveness of treatment approaches for both traumatic and, in
particular, non-traumatic knee pain conditions.
The present systematic review included a broad search strategy with different knee pain
conditions and interventions. Despite that, the systematic search was only able to include 15
studies, which is surprisingly few considering the high prevalence of knee pain and the costs
related to it.
Most of the studies are conducted in university hospitals, which could indicate some selec-
tion bias as hospitals might have a tradition to conduct more research, hence more economic
evaluations due to easier access to resources. Small clinics also provide surgical management
more frequently for patients with knee pain, but the patient population is different than
patients in a hospital setting. Therefore, it limits the transferability of the study results to other
settings and conclusions from the included studies should be drawn with caution.
Choice of treatment for knee pain depends on the condition and the site and severity of the
pain, but guidelines recommend a combination of education, advice, and physical therapy as
first-line treatment for most knee pain conditions[18–20,41,42]. ACL injury is one of the most
common traumatic knee injuries and most of the included studies evaluated the cost-effective-
ness of treatments for ACL injuries. Gottlob et al.[26], Stewart et al.[29], Farshad et al.[30], and
Kiadaliri et al.[31] found surgical management of ACL injury to be cost-effective when com-
pared to rehabilitation and physical therapy with increased costs, and greater benefits in terms
of QALYs. Thus, the cost-effective treatment approach for ACL injury seems to be surgical
management in younger patients. Still, it can be discussed if the increased benefits are worth
the increased costs. Mather et al.[27] showed similar results when assessing cost-effectiveness
of surgical management compared to non-surgical management, but the surgical management
was associated with cost savings and QALY gains. This indicated clear dominance of surgical
management over non-surgical management and the application of a WTP threshold was not
necessary. Exercise therapy and rehabilitation alone was not cost-effectiveness for managing
traumatic knee pain conditions like ACL injury in younger patients. When interpreting these
results one must bear in mind that the studies have differences in time horizons, perspectives
of the economic analyses, and different instruments for measuring QALYs. Furthermore, it is
time-consuming to attain full benefit of exercise and rehabilitation interventions and therefore
longer time horizons are needed to include all benefits of such non-invasive and non-pharma-
cological interventions. The study by Tan et al.[40] was the only one assessing the cost-effec-
tiveness of advice and information about non-traumatic knee pain by comparing exercise
therapy to advice and information alone. The setting in this study reflects the daily practice in
the clinic having patients with PFPS as these patients are given advice and information as well
as an integrated exercise program before referral for surgical interventions. The time horizon
was only one year, which might not be adequate as the actual clinical benefits of the exercise
intervention might be seen with a longer time horizon. However, a longer time horizon would
not amend the conclusion of the study as the intervention is associated with lower costs and
gain in benefits compared to advice and information alone.
Decisions regarding the cost-effectiveness of the interventions in the studies are drawn
based on different sets of rules for decision-making for the various settings and, therefore,
judgment on transferability and comparison of the studies must be performed with caution.
However, it can be discussed if the included studies can be used as a basis for decision-making
as the evidence is scarse and the study has highlighted the lack of knowledge on the cost-
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effectiveness of interventions aimed at a set of knee pain conditions, including tendinitis, bur-
sitis, dislocation of the knee cap, and MCL.
Methodological issues and comparability
It is good practice for conducting economic evaluations to include all relevant costs according
to the implied perspectives and time horizons[43]. The majority of the included studies
adopted a restricted perspective such as the NHS or a healthcare perspective, thus excluding
productivity costs. A few studies claimed to apply a societal perspective, but still did not
include costs related to lost productivity. Though the application of the different perspectives
may be in agreement with local recommendations, it hampers the comparability of the results
of the economic evaluations. In general, the studies showed that the interventions had only a
modest impact on quality of life, but the additional intervention costs were sufficiently modest
to ensure cost-effectiveness. Still, private payments and productivity costs have been shown to
constitute a significant share of the total costs of knee pain, for which reason the inclusion and
exclusion of such costs might have a sizeable impact on the cost-effectiveness of interventions.
Another factor that limits the accuracy of the reported benefits and economic outcomes is
the applied time horizon. Relatively short time horizons are likely to be inadequate in captur-
ing the actual benefits and full extent of the long-term costs. Studies with longer time horizons
may to a higher degree include all relevant costs and consequences and potentially attenuate
findings, but may potentially also produce conflicting cost-effectiveness results compared to
economic evaluations with shorter time horizons. For instance, if a lifetime perspective were
adopted in studies evaluating surgical compared to non-surgical strategies for treatment of
ACL injuries, it might be concluded that non-surgical interventions are cost-effective because
of the low costs of the interventions and the increased benefits achieved over the lifetime
course. However, removing studies with short-term time horizons in this review would not
affect the overall conclusions.
Conducting economic evaluations based on a single study or decision-analytic modelling
both has advantages and disadvantages. The most common type of trial-based economic evalu-
ations are those alongside a RCT. Although in general, some trials select the population ran-
domly from the target population, most of the trials do not sample their population randomly
[44,45]. This could violate the external validity of the studies and challenge their generalizabil-
ity. Nonetheless, having patient-specific data on both costs and benefits is attractive for analy-
ses. It ensures that the accumulation of effects and costs are correlated and enables analyses of
the relationship between cost and effect accumulation with adjustment for patients’ character-
istics. Although such studies are still undertaken and published, there is a growing use of
model-based economic evaluations. Model-based economic evaluations integrate and gathers
the best available evidence into a single decision analytical framework to inform on complex
and multidimensional medical decision problems. Most of the included studies conducted
model-based economic evaluations and might potentially reflect the target population. As
model-based economic evaluations are more generalizable it might be more appropriate to
conduct such economic evaluations[43].
The health economic impact of medical technologies is often only evaluated in a few settings
and as a result decision makers often face considerations of whether cost-effectiveness results
from a study conducted in another setting can be transferred to their own jurisdiction or if a
new study should be conducted. Due to resource constraints and/or time limits, the second
option might not always be possible, leaving the decision makers with existing studies as basis
for decision, though they may not reflect the decision makers’ decision situation. Consequently,
transferability of foreign study results is increasingly being recognized as an important research
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field[46]. All the identified studies were conducted in developed countries, including the United
States, United Kingdom and European countries. From a clinical perspective, the population in
these countries are expected to be somewhat similar and effectiveness of interventions might be
transferable. However, the cost-effectiveness results are less likely to be transferable across coun-
tries due to variability in the structure and delivery of healthcare systems, differences in costs of
healthcare services, and the diversity of usual care[47,48]. For example, it can be discussed if the
expected effectiveness of conservative or non-surgical treatment options can be transferred
from one country to another as it can vary in different countries and states in the USA. Trans-
ferability can also be difficult if the costs associated with an intervention is differs across coun-
tries and jurisdictions. Depending on the perspective of an economic evaluation, different costs
can be included due to delivery of healthcare services. The lack of transferability of results from
one country to another can enhance the conclusions of this review as it cannot be concluded if
the intervention is actually cost-effective in a particular country. However, Welte et al. devel-
oped a tool for managing the transfer of economic evaluation results which can be used to deter-
mine transferability of an economic evaluation to a target country[47]. Therefore,
implementing cost-effective interventions is not straightforward based on results of this review.
Association between health benefits and risk of interventions is differs in terms of complica-
tions, adverse events, instability, and compliance. For instance, there is a highere risk of post-
surgical adverse events such as rerupture, or failure of prothesis after surgical management of
different non-osteoarthritic knee pain conditions. This can result in lower effect of the treat-
ment and the ratio between costs and effects of the treatment will rise. Therefore, interventions
with a highere rates of adverse events tends to be not cost-effective.
Strengths and limitations
The present review displays particular strengths. The review was prospectively registered in
PROSPERO, which seeks to avoid duplication of studies and to reduce the risk of reporting
bias by enabling comparison of completed review with what was planned in the protocol. As
recommended, key electronic databases were searched by constructing free text and indexing
terms. No restrictions were made on the type of economic evaluation or the medical condi-
tions, except for osteoarthritis. Two independent reviewers managed the inclusion process as
well as the assessment of the methodological quality of the studies.
Nonetheless, our review poses some limitations. The search strings for the present system-
atic review were loosely based on the PICO search strategy. However, in the present study the
‘I‘ and the ‘C‘ were deliberately omitted to ensure a more inclusive search, as was in agreement
with our research question. A ‘well-built’ PICO question should include all four parts. Includ-
ing the two parts of the PICO might result in different studies found from the databases.
It is important to assess risk of bias in the included studies in a systematic review, as bias
can either overestimate or underestimate the true intervention effect[49]. Economic evalua-
tions need to be methodologically sound so the consequent healthcare decisions are ethically
defensible. No validated tool is available to assess risk of bias of economic evaluations, but the
CHEC checklist is recommended by the Cochrane to use to assess the methodological quality
[49]. The CHEC list was developed by a broad representation of experts on the quality assess-
ment of economic evaluations and they achieved consensus on the list of containing items.
However, the list does not analyse the quality of economic evaluations based on modelling
studies, which might cause bias as the CHEC list only assess the reporting of the economic
evaluation. It is sometimes difficult to ascertain if shortcomings in an economic evaluation is
due to poor reporting of economic evaluations or the actual quality of the health economic
models was poor. Inadequate reporting could be due to journals accepting a limited number of
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words in an article thus making extensive explanations almost impossible. Therefore, some of
the studies included in the present study that achieved a low score based on the CHEC list
might, in fact, be of better methodological quality and vice versa. Heterogeneity in terms of
study designs, populations, methods, interventions, and outcome measures meant that a nar-
rative summary was used and a formal meta-analysis of studies was not possible. It can there-
fore be discussed if such systematic reviews including economic evaluations can have an
implication for the decision-makers. Furthermore, the review included complicated interven-
tions (both surgical and non-surgical interventions) which are both difficult to be generalizable
and difficult to conduct. This makes it difficult to utilize the effects as well.
Conclusions
Despite the inclusive search strategy employed in the present systematic review, only 15 eco-
nomic evaluations were identified for inclusion in the review of economic evaluations on
interventions for non-arthritic knee pain conditions. The lack of evidence on the cost-effec-
tiveness of often-used interventions is disquieting considering the continuing need for effec-
tive interventions within health sectors under budgetary constraints. The heterogeneity of the
included studies limit their comparability and hinder the drawing of overall conclusions on
the comparable cost-effectiveness of interventions. The majority of the studies presented eco-
nomic evaluations of interventions for ACL injuries and were conducted in different countries
with different costs included. This might hinder transferability of the study conclusions to
other countries and settings. However, in general it appeared that surgical management is
cost-effective when compared to non-surgical management. Surgical management was com-
pared to another surgical management for other traumatic knee pain conditions such as knee
cartilage defects and meniscus injuries. There is no comparison of cost-effective non-surgical
management for these conditions and therefore drawing overall conclusions cannot be drawn.
Only one study compared exercise therapy for treatment of non-traumatic condition, PFPS, to
usual care. The evidence on cost-effectiveness of treatment approaches for non-traumatic knee
pain is inconclusive as there is currently only one study of PFPS and no studies assessing cost-
effectiveness of surgical management for this condition.
In general, the methodological quality of the economic evaluations ranged from medium to
high quality as assessed by use of the CHEC list. Nonetheless, the transferability of the studies
remains unassessed and firm conclusions on the cost-effectiveness of interventions cannot be
made. Future studies should focus on assessing cost-effectiveness of both traumatic and non-
traumatic knee pain interventions over a lifetime time horizon and apply a societal perspective
to include all relevant costs. Furthermore, lack of evidence indicates a need for future studies
to assess cost-effectiveness studies to ensure optimal resource use.
Supporting information
S1 PRISMA. The PRISMA list for the systematic review.
(PDF)
S1 Search strategy. Search strategy from the databases.
(PDF)
S1 Extraction form. An overall extraction form for all the included studies.
(PDF)
S1 CHEC list. Quality assessment of the included studies.
(XLSX)
Systematic review of cost-effective knee pain treatments
PLOS ONE | https://doi.org/10.1371/journal.pone.0209240 December 19, 2018 13 / 16
S1 Appendix. The CHEC list with the interpreted explanations.
(PDF)
Author Contributions
Conceptualization: Tamana Afzali.
Methodology: Tamana Afzali, Mia Vicki Fangel, Anne Sig Vestergaard.
Writing – original draft: Tamana Afzali.
Writing – review & editing: Tamana Afzali, Mia Vicki Fangel, Anne Sig Vestergaard, Michael
Skovdal Rathleff, Lars Holger Ehlers, Martin Bach Jensen.
References
1. Calmbach WL, Hutchens M. Evaluation of Patients Presenting with Knee Pain: Part I. History, Physical
Examination, Radiographs, and Laboratory Tests. Am Fam Physician. 2003; 68:907–12. PMID:
13678139
2. Rathleff MS, Roos EM, Olesen JL, Rasmussen S. High prevalence of daily and multi-site pain—a
cross-sectional population-based study among 3000 Danish adolescents. BMC Pediatr. 2013; 13:191.
https://doi.org/10.1186/1471-2431-13-191 PMID: 24252440
3. Rathleff CR, Olesen JL, Roos EM, Rasmussen S, Rathleff MS. Half of 12-15-year-olds with knee pain
still have pain after one year. Dan Med J. 2013; 60(11):1–5.
4. Calmbach W., Hutchens M. Evaluation of Patients Presenting with Knee Pain: Part II. Differential Diag-
nosis. Am Fam Physician. 2003; 68(5):907–12. PMID: 13678139
5. de Lucena GL, dos Santos Gomes C, Guerra RO. Prevalence and associated factors of Osgood-
Schlatter syndrome in a population-based sample of Brazilian adolescents. Am J Sports Med. 2011; 39
(2):415–20. https://doi.org/10.1177/0363546510383835 PMID: 21076014
6. Gage BE, McIlvain NM, Collins CL, Fields SK, Comstock RD. Epidemiology of 6.6 million knee injuries
presenting to United States emergency departments from 1999 through 2008. Acad Emerg Med. 2012;
19(4):378–85. https://doi.org/10.1111/j.1553-2712.2012.01315.x PMID: 22506941
7. Gianotti SM, Marshall SW, Hume PA, Bunt L. Incidence of anterior cruciate ligament injury and other
knee ligament injuries: A national population-based study. J Sci Med Sport. 2009; 12(6):622–7. https://
doi.org/10.1016/j.jsams.2008.07.005 PMID: 18835221
8. Finch CF, Kemp JL, Clapperton AJ. The incidence and burden of hospital-treated sports-related injury
in people aged 15+ years in Victoria, Australia, 2004–2010: A future epidemic of osteoarthritis?
Osteoarthr Cartil. 2015; 23(7):1138–43. A https://doi.org/10.1016/j.joca.2015.02.165 PMID: 25749009
9. Jinks C, Jordan KP, Blagojevic M, Croft P. Predictors of onset and progression of knee pain in adults liv-
ing in the community. A prospective study. Rheumatology. 2008; 47(3):368–74. https://doi.org/10.1093/
rheumatology/kem374 PMID: 18263594
10. Griffin LY, Agel J, Albohm MJ, Arendt EA, Dick RW, Garrett WE, et al. Noncontact Anterior Cruciate Lig-
ament Injuries: Risk Factors and Prevention Strategies. J Am Acad Orthop Surg. 2000;141–50. PMID:
10874221
11. Lohmander LS, Englund PM, Dahl LL. The Long-term Consequence of Anterior Cruciate Ligament and
Meniscus Injuries Osteoarthritis. Am J Sports Med. 2007; 35(10):1756–69. https://doi.org/10.1177/
0363546507307396 PMID: 17761605
12. Wilder F V., Hall BJ, Barrett JP, Lemrow NB. History of acute knee injury and osteoarthritis of the knee:
A prospective epidemiological assessment. The Clearwater Osteoarthritis Study. Osteoarthr Cartil.
2002; 10(8):611–6. PMID: 12479382
13. Roos EM. Joint injury causes knee osteoarthritis in young adults. Curr Opin Rheumatol. 2005;195–200.
PMID: 15711235
14. Webb R, Brammah T, Lunt M, Urwin M, Allison T, Symmons D. Opportunities for prevention of “clinically
significant” knee pain: Results from a population-based cross sectional survey. J Public Health (Bang-
kok). 2004; 26(3):277–84.
15. Hewett TE, Lindenfeld TN, Riccobene J V, Noyes FR. The effect of neuromuscular training on the inci-
dence of knee injury in female athletes: a prospective study. / Effet d’un entrainement neuromusculaire
sur l’incidence de blessures au genou chez des athletes feminines. Am J Sports Med. 1999; 27(6):699–
706. https://doi.org/10.1177/03635465990270060301 PMID: 10569353
Systematic review of cost-effective knee pain treatments
PLOS ONE | https://doi.org/10.1371/journal.pone.0209240 December 19, 2018 14 / 16
16. Griffin LY, Albohm MJ, Arendt E a, Bahr R, Beynnon BD, Demaio M, et al. Understanding and Prevent-
ing Noncontact Anterior Cruciate Ligament Injuries: A Review of the Hunt Valley II Meeting, January
2005. Am J Sports Med. 2006; 34(9):1512–32. https://doi.org/10.1177/0363546506286866 PMID:
16905673
17. Fernandes L, Hagen KB, Bijlsma JWJ, Andreassen O, Christensen P, Conaghan PG, et al. EULAR rec-
ommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann
Rheum Dis. 2013; 72(7):1125–35. https://doi.org/10.1136/annrheumdis-2012-202745 PMID: 23595142
18. Hootman JM, Dick R, Agel J. Epidemiology of Coiiegiate Injuries for 15 Sports: Summary and Recom-
mendations for Injury Prevention Initiatives. J Athl Train. 2007; 42(2):311–9. PMID: 17710181
19. Management of Anterior Cruciate Ligament Injuries. AAOS Clinical Guidelines. Available from: http://
www.orthoguidelines.org/guideline-detail?id=1251
20. New York Knee Injury Medical Treatment Guidelines. New York State Workers’ Compensation Board.
2014.
21. Logerstedt DS, Snyder-Mackler L, Ritter RC, Axe MJ, Godges J. Knee Pain and Mobility Impairments:
Meniscal and Articular Cartilage Lesions. J Orthop Sport Phys Ther. 2010; 40(6):A1–597.
22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement
for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions:
Explanation and elaboration. PLoS Med. 2009; 6(7).
23. Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological
quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Heal
Care. 2005; 21(2):240–5.
24. Fxtop. Inflation Calculator. 2017. Available from: http://fxtop.com/en/inflation-calculator.php?A=
14738&C1=EUR&INDICE=NLCPI2013&DD1=01&MM1=01&YYYY1=2010&DD2=01&MM2=
01&YYYY2=2016&btnOK=Compute+actual+value
25. Euroinvestor. Valutakurser. Available from: http://www.valutakurser.dk
26. Gottlob CA, Baker CL, Pellissier JM, Colvin L. Cost effectiveness of anterior cruciate ligament recon-
struction in young adults. Clin Orthop Relat Res. 1999;272–82. PMID: 10546625
27. Mather RC 3rd, Koenig L, Kocher MS, Dall TM, Gallo P, Scott DJ, et al. Societal and economic impact
of anterior cruciate ligament tears. J Bone Joint Surg Am. 2013; 95(19):1751–9. https://doi.org/10.2106/
JBJS.L.01705 PMID: 24088967
28. Mather RC III, Hettrich CM, Dunn WR, Cole BJ, Koeing L, Bach BR. Cost-Effectiveness Analysis of
Early Reconstruction versus Rehabilitation and Delayed Reconstruction for ACL Tears. Am J Sports
Med. 2014; 42(7):1583–91. https://doi.org/10.1177/0363546514530866 PMID: 24801663
29. Stewart BA, Momaya AM, Silverstein MD, Lintner D. The Cost-Effectiveness of Anterior Cruciate Liga-
ment Reconstruction in Competitive Athletes. Am J Sports Med. 2016;363546516664719.
30. Farshad M, Gerber C, Meyer DC, Schwab A, Blank PR, Szucs T. Reconstruction versus conservative
treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis. BMC Health Serv
Res. 2011 Nov; 11:317. https://doi.org/10.1186/1472-6963-11-317 PMID: 22098703
31. Kiadaliri AA, Englund M, Lohmander LS, Steen Carlsson K, Frobell RB. No economic benefit of early
knee reconstruction over optional delayed reconstruction for ACL tears: registry enriched randomised
controlled trial data. Br J Sports Med. 2016;558–63.
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